期刊文献+

干细胞治疗后继发或转化肿瘤的风险性 被引量:1

原文传递
导出
摘要 干细胞用于再生医学起始于1968年,至今已有40余年历史。近年来,干细胞研究迅速发展,用于修复损伤的组织器官,治疗退行性疾病、免疫性疾病及肿瘤等.但对应用干细胞存在的风险,特别是继发或转化肿瘤的风险尚存不同的认识,现综述如下。一、干细胞治疗后继发或转化肿瘤的临床报道成体干细胞大致分为造血干细胞和非造血干细胞两大类。前者多用于治疗多种血液病或肿瘤,其后发生的肿瘤称为继发肿瘤;而后者,特别是间质干细胞多用于非肿瘤疾病,其后发生的肿瘤则称为转化肿瘤。
作者 卢世璧 袁玫
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第24期1725-1727,共3页 National Medical Journal of China
  • 相关文献

参考文献4

二级参考文献86

  • 1毛晓波,曾秋棠,王祥,曹林生.同种异体骨髓基质细胞移植促进心肌梗死后血管新生[J].中国病理生理杂志,2005,21(1):158-158. 被引量:3
  • 2毛晓波,曾秋棠,王祥,曹林生.骨髓基质细胞移植促进心肌梗塞后血管新生机制的研究[J].中国应用生理学杂志,2005,21(3):311-314. 被引量:2
  • 3郭豫涛,李小鹰,鲁小春,吴迪,姚克群,陈平,马康涛,周春燕.钙离子ATP酶2a基因修饰的骨髓干细胞移植治疗大鼠心肌梗死后心力衰竭的研究[J].中华医学杂志,2006,86(12):826-831. 被引量:5
  • 4祁春梅,马根山,刘乃丰,陈忠,沈成兴,刘孝钧,胡耀鹏,苏亚民,李璇,滕皋军,居胜红,张晓黎,顾宁.磁探针标记骨髓干细胞移植治疗急性心肌梗死的MRI示踪研究[J].中华医学杂志,2007,87(22):1523-1526. 被引量:6
  • 5Mauney JR, Blumberg J, PirumM, et al. Osteogenic differentiationof human bone marrow stromal cells on partially demineralized bones caffolds in vitro. Tissue Eng, 2004, 10(142): 81-92.
  • 6Kon E, Muraglia A, Corsi A, et al. Autologous bone marrow stromalcells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical2 size defects of sheep long bones. J Biomed Mater Res, 2000, 49(3): 328-337.
  • 7Rubio D, Garcia-Castro J, Martin MC, et al. Spontaneous human adult stem cell transformation. Cancer Res, 2005, 65(8): 3035-3039.
  • 8Miura M, Miura Y, Padilla-NashHM, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.Stem Cells, 2006, 24(4): 1095-1103.
  • 9Li S, Gao Y, Tokuyama T, et al. Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett, 2007, 251(2): 220-227.
  • 10Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA, 2001, 98: 10344-10349.

共引文献21

同被引文献36

  • 1李慧,孙凌云.间质干细胞的免疫调节及免疫治疗作用研究进展[J].中华医学杂志,2006,86(7):501-503. 被引量:15
  • 2Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of muhipotent stem cells. Mol Biol Cell, 2002, 13: 4279 -4295.
  • 3Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Ceils, 2006, 24: 1294-1301.
  • 4Gronthos S, Franklin DM, Leddy HA, et al. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol, 2001, 189 : 54-63.
  • 5Dennis JE, Carbillet JP, Caplan AI, et al. The STRO-I : marrow cell population is muhipotential. Cells Tissues Organs, 2002, 170, 73-82.
  • 6Mizuno H, Tobita M, Uysal AC. Concise review: Adipose- derived stem cells as a novel tool for future regenerative medicine. Stem Cells, 2012, 30: 804-810.
  • 7Chandra V, Swetha G, Muthyala S, et al. Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. FLoS One, 2011, 6: e20615.
  • 8Moviglia GA, Blasetti N, Zarate JO, et al. In vitro differentiation of adult adipose mesenchymal stem cells into retinal progenitor cells. Ophthalmic Res, 2012, 48 Suppl 1 : 1-5.
  • 9Soleymaninejadian E, Pramanik K, Samadian E. Immunomodulatory properties of mesenchymal stem cells : cytokines and factors. Am J Reprod Immunol, 2012, 67 : 1-8.
  • 10Yafiez R, Oviedo A, Aldea M, et al. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp Cell Res, 2010, 316: 3109-3123.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部